Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2020-07493 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 2020-0493 | Other Identifier | M D Anderson Cancer Center |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality of care through telemedicine in patients with brain cancer may help doctors to improve the delivery of care through this modality.
PRIMARY OBJECTIVE:
I. To evaluate the patient-perceived quality of care by group (telemedicine versus in-person visits) in patients with central nervous system (CNS) cancer.
SECONDARY OBJECTIVES:
I. To characterize the visits provided by telemedicine compared to those in-person.
II. To contrast the average time spent on telemedicine visits compared to in-person visits, and the delay between visit order placement and visit occurring.
III. To evaluate the domains of patient care addressed on a telemedicine visit versus in-person visit per documentation, including (1) treatment planning, (2) symptom burden, (3) goals of care.
IV. To evaluate frequency of acute care sought (through emergency room or urgent care clinic) within 30 days of encounter in telemedicine visit versus (vs) in-person visit.
V. The impact of patient and clinical characteristics on perceived quality of care in the context of covariate-adjusted modeling.
OUTLINE:
Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Observational (survey, medical chart review) | Patients complete a survey related to their perceived quality of care via telephone and have their medical chart reviewed prospectively. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Electronic Health Record Review | Other | Review of medical chart |
|
| Measure | Description | Time Frame |
|---|---|---|
| Survey response to question 6 of the quality of care survey ("I felt I received good medical care during this encounter") | Survey responses will be summarized by ordinal category as counts with percentages, separately by group. Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval. | through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Care Survey | Will separately estimate the proportion of each ordinal level of each group with 95% confidence interval. | through study completion, an average of 1 year |
| Patients and clinical characteristics |
Not provided
Inclusion Criteria:
Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with encounters at the Brain and Spine Center between 4/20/2020 and either (1) 8/30/2020 or (2) date that the state of emergency secondary to the COVID-19 pandemic is declared terminated in the United States of America- whichever date is earlier
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Barbara J O'Brien, MD | Contact | 713-794-4380 | bjobrien@mdanderson.org |
| Name | Affiliation | Role |
|---|---|---|
| Barbara J O'Brien, MD | M.D. Anderson Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States |
Not provided
| Label | URL |
|---|---|
| University of Texas MD Anderson Cancer Center Website | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
| Survey Administration | Other | Complete survey |
|
Differences between groups will be assessed by 2-sample 2-sided t-test and Mann-Whitney test, Fisher's exact test, or chi-square test.
| Baseline |
| Interactive time spent during visit | Will be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test. | through study completion, an average of 1 year |
| Time from visit order placement to visit occurring | Will be summarized by group per mean, median, standard deviation, and range. Differences between groups will be assessed by t-test and Mann-Whitney test. | through study completion, an average of 1 year |
| Domains of patient care addressed during a visit, including treatment planning, symptom burden, and goals of care | Will be summarized as counts with percentages by group. Differences between groups will be assessed by chi-square test. | through study completion, an average of 1 year |
| Incidence of acute care sought (through emergency room or urgent care clinic) | Will be summarized as counts with percentages by group. Differences between groups will be provisionally assessed by Fisher's exact test. | Within 30 days of encounter |
| ID | Term |
|---|---|
| D016543 | Central Nervous System Neoplasms |
| D008577 | Meningeal Neoplasms |
| D001932 | Brain Neoplasms |
| ID | Term |
|---|---|
| D009423 | Nervous System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D009422 | Nervous System Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided